Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse.
Adolescent
Adult
Aged
Child
Cohort Studies
Disease-Free Survival
Female
Humans
Male
Margins of Excision
Middle Aged
Neoplasm Recurrence, Local
/ epidemiology
Neurosurgical Procedures
/ methods
Osteosarcoma
/ mortality
Retrospective Studies
Skull Base
/ pathology
Skull Base Neoplasms
/ mortality
Young Adult
Cancer
Malignancy
Osteosarcoma
Skull base
Surgery
Journal
Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914
Informations de publication
Date de publication:
01 01 2020
01 01 2020
Historique:
received:
08
03
2019
accepted:
02
07
2019
pubmed:
14
9
2019
medline:
25
8
2020
entrez:
14
9
2019
Statut:
ppublish
Résumé
Skull base osteosarcomas are aggressive neoplasms characterized by bony invasion and extracompartmental/extra-osseous soft tissue extension that pose obstacles to achieving complete resection. Management is further complicated by the paucity of data regarding the efficacy of surgery within the treatment paradigm. To identify the impact of margin status on local progression free survival (PFS) and disease specific survival (DSS). A retrospective review was performed of 36 patients with osteosarcoma who underwent gross total resection with negative margins (R0), or positive margins (R1). Patient demographics, prior treatments, relapse patterns, and survival were collected. Univariate analysis was performed to determine the impact of margin status on the PFS (primary outcome) and DSS (secondary outcome). R0 resection was achieved in 67%, 25% patients had local recurrence, and 19.4% patients had distant metastasis. In assessing the entire cohort, R0 resections had improved DSS (P = .002) and PFS (P = .04). In chemotherapy-naïve patients, R0 resections also had improved impact on PFS (P = .04) and DSS (P = .027). For radiation-naïve patients, improvements in PFS (P = .026) and DSS (P = .031) were also noted. Skull base osteosarcomas present management challenges in which both local and systemic disease progression is the cause of mortality. Achieving R0 resections significantly improves PFS and DSS in treatment-naïve patients within multimodality treatment paradigms. Salvage surgery may benefit in patients after failing previous radiation and chemotherapy treatments. Further work is needed to determine optimal treatment strategies. These data represent the largest series reported to date.
Sections du résumé
BACKGROUND
Skull base osteosarcomas are aggressive neoplasms characterized by bony invasion and extracompartmental/extra-osseous soft tissue extension that pose obstacles to achieving complete resection. Management is further complicated by the paucity of data regarding the efficacy of surgery within the treatment paradigm.
OBJECTIVE
To identify the impact of margin status on local progression free survival (PFS) and disease specific survival (DSS).
METHODS
A retrospective review was performed of 36 patients with osteosarcoma who underwent gross total resection with negative margins (R0), or positive margins (R1). Patient demographics, prior treatments, relapse patterns, and survival were collected. Univariate analysis was performed to determine the impact of margin status on the PFS (primary outcome) and DSS (secondary outcome).
RESULTS
R0 resection was achieved in 67%, 25% patients had local recurrence, and 19.4% patients had distant metastasis. In assessing the entire cohort, R0 resections had improved DSS (P = .002) and PFS (P = .04). In chemotherapy-naïve patients, R0 resections also had improved impact on PFS (P = .04) and DSS (P = .027). For radiation-naïve patients, improvements in PFS (P = .026) and DSS (P = .031) were also noted.
CONCLUSION
Skull base osteosarcomas present management challenges in which both local and systemic disease progression is the cause of mortality. Achieving R0 resections significantly improves PFS and DSS in treatment-naïve patients within multimodality treatment paradigms. Salvage surgery may benefit in patients after failing previous radiation and chemotherapy treatments. Further work is needed to determine optimal treatment strategies. These data represent the largest series reported to date.
Identifiants
pubmed: 31515560
pii: 5568465
doi: 10.1093/neuros/nyz360
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E23-E32Informations de copyright
Copyright © 2019 by the Congress of Neurological Surgeons.